Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
14 pending office actions • 12 art units • 14 examiners • 0 of 14 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days
Danmarks Tekniske Universitet currently faces 14 pending office actions in the Biotechnology & Pharmaceuticals technology area. The prosecution of these matters is decentralized, involving 14 distinct examiners. This distribution indicates that each of the 14 distinct examiners is handling a single case for the university at this time.
The portfolio spans 12 distinct art units, demonstrating a broad technical reach within the biotechnology sector. KHAN, AMINA S is the busiest examiner, though they are only responsible for 1 pending office action. This distribution suggests that the university's patent strategy involves a variety of specific sub-disciplines, as evidenced by the 12 distinct art units relative to the total pending workload.
Practitioners should observe that with 14 distinct examiners, there is very little overlap in the personnel reviewing the university's applications. This diversity requires a flexible approach to prosecution, as different individuals are providing feedback across the various specialized units. The 1 pending office action per examiner ensures no single individual dominates the university's current prosecution queue.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (7%) |
| §103 only | 2 (14%) |
| §102 only | 1 (7%) |
| Double-patenting only | 1 (7%) |
| Multi-statute (no §101) | 9 (64%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KHAN, AMINA S | 1 | 47.5% | +43.0% |
| SWIFT, CANDICE LEE | 1 | 57.5% | +36.0% |
| KUNEMUND, ROBERT M | 1 | 82.0% | +13.2% |
| RAGHU, GANAPATHIRAM | 1 | 73.6% | +26.4% |
| MULDER, SCOTT EVAN | 1 | 41.2% | +65.2% |
| BRADLEY, CHRISTINA | 1 | 62.6% | +33.3% |
| NGUYEN, HENRY H | 1 | 63.7% | +37.2% |
| RODGERS, ARIEL M | 1 | 15.4% | +26.9% |
| RIPA, BRYAN D | 1 | 53.9% | +37.2% |
| LIPPOLIS, ALEXANDRA ROSE | 1 | 46.9% | +59.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257202 | TWO-DIMENSIONAL MATERIAL AND HETEROSTRUCTURES ON AN INTERMEDIATE POLYMER TRANSFER LAYER AND THEIR FABRICATION | KUNEMUND, ROBERT M | 29d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17797986 | COMPOSITIONS AND METHODS FOR TARGETING, EDITING OR MODIFYING HUMAN GENES | LIPPOLIS, ALEXANDRA ROSE | 5d overdue |
| 17780002 | CONSTRUCTS, COMPOSITIONS AND METHODS THEREOF HAVING IMPROVED GENOME EDITING EFFICIENCY AND SPECIFICITY | GROOMS, TIFFANY NICOLE | 72d |
| 19108219 | PHOTOCLEAVAGE OF INDICAN | KHAN, AMINA S | — |
| 18688433 | INCREASING GROWTH OF A CO2 FIXING THERMOPHILE BACTERIUM | SWIFT, CANDICE LEE | — |
| 18564150 | METHODS FOR PRODUCING BETALAINS IN YEAST | RAGHU, GANAPATHIRAM | — |
| 18563026 | MUTANT RNASE E FOR ENHANCING RECOMBINANT PROTEIN EXPRESSION | MULDER, SCOTT EVAN | — |
| 18556402 | SMALL HYDROPHOBIC PROTEIN DRUG CONJUGATES AND USES THEREOF | BRADLEY, CHRISTINA | — |
| 18041455 | METHODS, ASSEMBLY AND SYSTEM FOR HIGH-THROUGHPUT, PARALLEL MONITORING OF REACTION SYSTEMS | NGUYEN, HENRY H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17797986 | COMPOSITIONS AND METHODS FOR TARGETING, EDITING OR MODIFYING HUMAN GENES | LIPPOLIS, ALEXANDRA ROSE | 5d overdue |
| 17905282 | Electrochemical ammonia synthesis | RIPA, BRYAN D | 8d |
| 18257202 | TWO-DIMENSIONAL MATERIAL AND HETEROSTRUCTURES ON AN INTERMEDIATE POLYMER TRANSFER LAYER AND THEIR FABRICATION | KUNEMUND, ROBERT M | 29d |
| 19108219 | PHOTOCLEAVAGE OF INDICAN | KHAN, AMINA S | — |
| 18688433 | INCREASING GROWTH OF A CO2 FIXING THERMOPHILE BACTERIUM | SWIFT, CANDICE LEE | — |
| 18564150 | METHODS FOR PRODUCING BETALAINS IN YEAST | RAGHU, GANAPATHIRAM | — |
| 18563026 | MUTANT RNASE E FOR ENHANCING RECOMBINANT PROTEIN EXPRESSION | MULDER, SCOTT EVAN | — |
| 18556402 | SMALL HYDROPHOBIC PROTEIN DRUG CONJUGATES AND USES THEREOF | BRADLEY, CHRISTINA | — |
| Art Unit | Apps |
|---|---|
| 1637 | 2 |
| 1657 | 1 |
| 1714 | 1 |
| 1652 | 1 |
| 1656 | 1 |
| 1654 | 1 |
| 1758 | 1 |
| 1792 | 1 |
| 1794 | 1 |
| 1796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19108219 | PHOTOCLEAVAGE OF INDICAN | KHAN, AMINA S | — | §101§102§103§112 | Non-Final OA | — | Pending | Mar 03, 2025 |
| 18688433 | INCREASING GROWTH OF A CO2 FIXING THERMOPHILE BACTERIUM | SWIFT, CANDICE LEE | 1657 | §103§112 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18257202 | TWO-DIMENSIONAL MATERIAL AND HETEROSTRUCTURES ON AN INTERMEDIATE POLYMER TRANSFER LAYER AND THEIR FABRICATION | KUNEMUND, ROBERT M | 1714 | §102 | Final Rejection | 29d | Pending | Dec 20, 2023 |
| 18564150 | METHODS FOR PRODUCING BETALAINS IN YEAST | RAGHU, GANAPATHIRAM | 1652 | §103§112 | Final Rejection | — | Pending | Nov 27, 2023 |
| 18563026 | MUTANT RNASE E FOR ENHANCING RECOMBINANT PROTEIN EXPRESSION | MULDER, SCOTT EVAN | 1656 | §103§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18556402 | SMALL HYDROPHOBIC PROTEIN DRUG CONJUGATES AND USES THEREOF | BRADLEY, CHRISTINA | 1654 | §102§112 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18041455 | METHODS, ASSEMBLY AND SYSTEM FOR HIGH-THROUGHPUT, PARALLEL MONITORING OF REACTION SYSTEMS | NGUYEN, HENRY H | 1758 | §103§112 | Non-Final OA | — | Pending | Feb 13, 2023 |
| 17920061 | PERMEABILIZED MICROBIAL CELL CATALYSTS | RODGERS, ARIEL M | 1792 | §103 | Non-Final OA | — | Pending | Oct 20, 2022 |
| 17905282 | Electrochemical ammonia synthesis | RIPA, BRYAN D | 1794 | §103 | Final Rejection | 8d | Pending | Aug 30, 2022 |
| 17797986 | COMPOSITIONS AND METHODS FOR TARGETING, EDITING OR MODIFYING HUMAN GENES | LIPPOLIS, ALEXANDRA ROSE | 1637 | §102§103 | Non-Final OA | 5d overdue | Pending | Aug 05, 2022 |
| 17787437 | CONTRACTILE TISSUE-BASED ANALYSIS DEVICE | SHI, TINGCHEN | 1796 | §102§103§112 | Final Rejection | — | Pending | Jun 20, 2022 |
| 17780002 | CONSTRUCTS, COMPOSITIONS AND METHODS THEREOF HAVING IMPROVED GENOME EDITING EFFICIENCY AND SPECIFICITY | GROOMS, TIFFANY NICOLE | 1637 | §103§112 | Non-Final OA | 72d | Pending | May 25, 2022 |
| 17776129 | A QUANTUM RANDOM NUMBER GENERATOR | KLOSTERMAN II, JEROME ANTHONY | 2182 | §103§112 | Non-Final OA | — | Pending | May 11, 2022 |
| 17090706 | N-Glycosylation | PENNINGTON, KATIE LEIGH | 1634 | DP | Non-Final OA | 98d overdue | Pending | Nov 05, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial